Otmar Schaaf - Concepedia

Author

Otmar Schaaf

Boehringer Ingelheim (Austria)

Also Known As

O. Schaaf, Otmar Schaaf

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (Austria)Max Planck Institute for Chemical Ecology Max Planck Society Boehringer Ingelheim (Germany)University of Bayreuth

About

Otmar Schaaf is an author at Boehringer Ingelheim (Austria) specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	712
2	Biochemistry	6	6	456
3	Natural Sciences	4	4	284
4	Engineering	1	1	65
5	Public Health	1	1	13

Otmar Schaaf

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth Dong-Sung Kim, Lorenz Herdeis, Dorothea Rudolph, Nature	2023	448
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor Laetitia J. Martin, Manfred Koegl, Gerd Bader, Journal of Medicinal Chemistry Molecular BiologyCancer BiologyTumor BiologyIndividual SubunitsStructure-based Design	2016	219
Target-induced formation of neuraminidase inhibitors from <i>in vitro</i> virtual combinatorial libraries Matthias Hochgürtel, Heiko Kroth, Dorothea Piecha, Proceedings of the National Academy of Sciences Combinatorial ChemistryDrug TargetBioorganic ChemistryMolecular BiologyPharmaceutical Chemistry	2002	136
Rapid and sensitive analysis of azadirachtin and related triterpenoids from Neem (Azadirachta indica) by high-performance liquid chromatography–atmospheric pressure chemical ionization mass spectrometry Otmar Schaaf, Andrew P. Jarvis, S Esch, Journal of Chromatography A BiochemistryMedicineSensitive AnalysisMass SpectrometryAnalytical Chemistry	2000	107
Ketones as Building Blocks for Dynamic Combinatorial Libraries: Highly Active Neuraminidase Inhibitors Generated via Selection Pressure of the Biological Target Matthias Hochgürtel, Ralf Biesinger, Heiko Kroth, Journal of Medicinal Chemistry Combinatorial ChemistryBuilding BlocksTarget EnzymeDrug TargetBioorganic Chemistry	2003	104
A Novel RAF Kinase Inhibitor with DFG-Out–Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue Hyperproliferation Irene C. Waizenegger, Anke Baum, Steffen Steurer, Molecular Cancer Therapeutics Braf-mutant MelanomasPathologyCancer BiologyTumor BiologyReceptor Tyrosine Kinase	2016	89
3-Hydroxy-3-phenylpropanoic acid is an intermediate in the biosynthesis of benzoic acid and salicylic acid but benzaldehyde is not Andrew P. Jarvis, Otmar Schaaf, Neil J. Oldham Planta BiosynthesisEngineeringBiotransformationBiochemistryBenzoic Acid	2000	65
Transformation of steroids by Bacillus strains isolated from the foregut of water beetles (Coleoptera:Dytiscidae): I. Metabolism of androst-4-en-3,17-dione (AD) Otmar Schaaf, Konrad Dettner The Journal of Steroid Biochemistry and Molecular Biology BiologyI. MetabolismBiosynthesisBiotransformationBacillus Strains	1998	23
A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway Melanie Wurm, Otmar Schaaf, Katharina Reutner, Molecular Cancer Therapeutics	2021	23
Transformation of steroids by Bacillus strains isolated from the foregut of water beetles (Coleoptera: Dytiscidae): II. Metabolism of 3β-hydroxypregn-5-en-20-one (pregnenolone) Otmar Schaaf, Konrad Dettner The Journal of Steroid Biochemistry and Molecular Biology BiologyBiosynthesisBacillus StrainsBiochemistryNatural Sciences	2000	21

Page 1